Table 1. The clinicopathological characteristics of patients in the cohort.
| Factors | GR | PR | P |
|---|---|---|---|
| Gender | 0.311 | ||
| Male | 20 | 19 | |
| Female | 0 | 1 | |
| Age, years | 1.000 | ||
| >60 | 10 | 10 | |
| ≤60 | 10 | 10 | |
| Weight loss | 0.736 | ||
| Yes | 13 | 14 | |
| No | 7 | 6 | |
| Dysphagia, month | 1.000 | ||
| ≤1 | 10 | 10 | |
| >1 | 10 | 10 | |
| Smoking | 0.633 | ||
| Ever | 17 | 18 | |
| Never | 3 | 2 | |
| Drinking | 0.027 | ||
| Ever | 6 | 13 | |
| Never | 14 | 7 | |
| Tumor location | 1.000 | ||
| Upper/middle | 17 | 17 | |
| Lower | 3 | 3 | |
| Tumor length, cm | 0.027 | ||
| <8 | 14 | 7 | |
| ≥8 | 6 | 13 | |
| Tumor grade | 0.001 | ||
| G1/Gx | 16 | 6 | |
| G2/G3 | 4 | 14 | |
| cT status | 0.256 | ||
| T2/3 | 17 | 14 | |
| T4 | 3 | 6 | |
| cN status | 1.000 | ||
| N− | 7 | 7 | |
| N+ | 13 | 13 | |
| Chemotherapy regimen | 0.197 | ||
| PF | 10 | 14 | |
| NP | 10 | 6 | |
| Interval between NCRT and surgery, weeks | 0.327 | ||
| >4 | 14 | 11 | |
| ≤4 | 6 | 9 |
GR, good responder; PR, poor responder; PF, 5-fluorouracil + cisplatin; NP, vinorelbine + cisplatin.